CRACKCast E078 - ACS Part B
CanadiEM Podcasts: CRACKCast, ClerkCast, CarmsCast, First Year Diaries · Brent Thoma
May 18, 201738m 20s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Here is the follow-up to the mammoth ACS chapter. This one has some key factoids to put into your mind map / memory pallace / organic computer.
- List Sgarbossa criteria for AMI in pre-existing LBBB
- What is Takotsubo cardiomyopathy and how does it present?
- Describe the kinetics of cardiac biomarkers (Troponins and CK)
- List DDx for ↑ Troponin
- What is the utility of CTA in the diagnosis of MI?
- What is the role of ED-based chest pain centers?
- List 3 phases of delay in the management of AMI; and describe the time-points in ED management of AMI.
- What are door-to-needle and door-to-balloon timelines by AHA recommendations?
- Describe the mechanism of action and indications/contraindications for
- Nitroglycerin
- Morphine
- BBlockers
- ACE-I
- Antiplatelet Therapies
- Anti-thrombins
- Describe eligibility criteria for Fibrinolytics
- List contraindications to Fibrinolytic therapy in MI
- What is the utility of Rescue PCI and Facilitated PCI?
- List 5 indications for Rescue PCI
- Describe factors assisting with decision to utilize PCI or thrombolytics
- In NSTEMI, who will benefit from an early invasive strategy of management?
Wise Cracks:
- What is the HEART Score?
- What is the management of ACS in the setting of recent cocaine use?
- How is STEMI diagnosed in the setting of LBBB?
- How is STEMI diagnosed in the setting of a ventricular pacemaker?
- When should you be getting a 15 lead ECG?